BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World J Gastroenterol 2019; 25(45): 6579-6606 [PMID: 31832000 DOI: 10.3748/wjg.v25.i45.6579]
URL: https://www.wjgnet.com/1948-5182/full/v25/i45/6579.htm
Number Citing Articles
1
Hauke Thomsen, Xinjun Li, Kristina Sundquist, Jan Sundquist, Asta Försti, Kari Hemminki, Gianfranco D. Alpini. Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseasesPLOS ONE 2020; 15(10): e0240794 doi: 10.1371/journal.pone.0240794
2
Weronika Domerecka, Anna Kowalska-Kępczyńska, Agata Michalak, Iwona Homa-Mlak, Radosław Mlak, Halina Cichoż-Lach, Teresa Małecka-Massalska. Etiopathogenesis and Diagnostic Strategies in Autoimmune HepatitisDiagnostics 2021; 11(8): 1418 doi: 10.3390/diagnostics11081418
3
Akihiro Yamaguchi, Toshiaki Teratani, Po‐sung Chu, Takahiro Suzuki, Nobuhito Taniki, Yohei Mikami, Shunsuke Shiba, Rei Morikawa, Takeru Amiya, Ryo Aoki, Takanori Kanai, Nobuhiro Nakamoto. Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented MiceHepatology Communications 2021; 5(9): 1555 doi: 10.1002/hep4.1742
4
Albert J. Czaja. Examining micro-ribonucleic acids as diagnostic and therapeutic prospects in autoimmune hepatitisExpert Review of Clinical Immunology 2022; 18(6): 591 doi: 10.1080/1744666X.2022.2074839
5
Albert J. Czaja. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune HepatitisDigestive Diseases and Sciences 2022; 67(4): 1163 doi: 10.1007/s10620-021-06968-6
6
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver DiseasesFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196
7
Julián David Martínez-Marín, Sandra Consuelo Henao-Riveros, Martín Alonso Garzón-Olarte. Hepatopatías autoinmunes. Hallazgos clínicos y de laboratorio en pacientes de un hospital de referencia nacionalHepatología 2021; : 355 doi: 10.52784/27112330.140
8
Jean-Charles Duclos-Vallée, Dominique Debray, Eleonora De Martin, Emilie Le Beux, Alexandre Louvet. Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitisClinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101871 doi: 10.1016/j.clinre.2022.101871
9
Taiba Jibril Afaa, Kokou Hefoume Amegan-Aho, Matilda Tierenye Dono, Eric Odei, Yaw Asante Awuku, Nikhil Pai. Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan AfricaPLOS ONE 2020; 15(12): e0239964 doi: 10.1371/journal.pone.0239964
10
Ana Lleo, Nora Cazzagon, Cristina Rigamonti, Giuseppe Cabibbo, Quirino Lai, Luigi Muratori, Marco Carbone. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injuryDigestive and Liver Disease 2022; 54(6): 722 doi: 10.1016/j.dld.2022.03.014
11
Albert J Czaja. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver diseaseWorld Journal of Gastroenterology 2021; 27(25): 3705-3733 doi: 10.3748/wjg.v27.i25.3705
12
Nikolaos K. Gatselis, Kalliopi Azariadis, Aggeliki Lyberopoulou, George N. Dalekos. Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitisJournal of Translational Autoimmunity 2021; 4: 100126 doi: 10.1016/j.jtauto.2021.100126
13
Albert J. Czaja. Advancing Biologic Therapy for Refractory Autoimmune HepatitisDigestive Diseases and Sciences 2022;  doi: 10.1007/s10620-021-07378-4
14
Surya P. Pandey, Mackenzie J. Bender, Alex C. McPherson, Catherine M. Phelps, Luzmariel Medina Sanchez, Mohit Rana, Lee Hedden, Kishan A. Sangani, Li Chen, Jake H. Shapira, Magdalena Siller, Chhavi Goel, Elena F. Verdú, Bana Jabri, Alexander Chang, Uma R. Chandran, Steven J. Mullett, Stacy G. Wendell, Aatur D. Singhi, Jeremy S. Tilstra, Joseph F. Pierre, Gavin E. Arteel, Reinhard Hinterleitner, Marlies Meisel. Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitisCell Host & Microbe 2022; 30(7): 1003 doi: 10.1016/j.chom.2022.05.006
15
Albert J. Czaja. Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune HepatitisDigestive Diseases and Sciences 2021; 66(8): 2493 doi: 10.1007/s10620-020-06562-2
16
Rie Sakata, Po-sung Chu, Miho Kawaida, Katsura Emoto, Masatoshi Sakurai, Risa Nishida, Keisuke Asakura, Rei Morikawa, Nobuhito Taniki, Keisuke Kataoka, Takanori Kanai, Nobuhiro Nakamoto. Concurrent <i>de novo</i> Thymoma-associated Paraneoplastic Type 1 Autoimmune Hepatitis and Pure Red Cell Aplasia After Thymectomy: A Case Report and Literature ReviewInternal Medicine 2022;  doi: 10.2169/internalmedicine.9743-22
17
Rossella Fasano, Eleonora Malerba, Marcella Prete, Antonio Giovanni Solimando, Alessio Buonavoglia, Nicola Silvestris, Patrizia Leone, Vito Racanelli. Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune HepatitisFrontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.814155
18
Sarah J. Blossom, Christian V. Cabanlong, Kanan K. Vyas. Developmental trichloroethylene exposure enhances predictive markers of autoimmunity in a sex-specific manner in disease-resistant female miceToxicology and Applied Pharmacology 2022; 454: 116233 doi: 10.1016/j.taap.2022.116233